Direct oral anticoagulant (DOACs) prescribing practices of members of the Society of Gynecologic Oncology and American Society of Clinical Oncology

Medicine & Life Sciences

• Medical Oncology 100%
• Anticoagulants 78%
• Venous Thromboembolism 40%
• Second Primary Neoplasms 32%
• Drug Therapy 22%
• Low Molecular Weight Heparin 21%
• Prescriptions 15%
• Gynecologic Surgical Procedures 11%
• Standard of Care 9%
• Consensus 8%
• Psychology Recognition 8%
• Organizations 7%
• Clinical Trials 6%
• Neoplasms 6%
• Guidelines 6%
• Physicians 5%
• Costs and Cost Analysis 5%
• Morbidity 5%
• Safety 5%
• Injections 5%
• Mortality 4%
• Therapeutics 3%